8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2021 / Randomized comparative trial
Sixty patients with female pattern hair loss were randomized to receive either pumpkin seed oil (n = 30) or minoxidil 5% foam (n = 30) for 3 months. In the pumpkin seed oil group, hair shaft diversity significantly decreased from 30.5 ± 6.2% to 24.0 ± 4.02 (P < .001) and vellus hairs decreased from 22.5 ± 4.9 to 15.8 ± 2.2 (P < .001), while upright regrowing hairs increased from 0.13 ± 0.5 to 0.9 ± 1.0 (P < .001). In the minoxidil group, hair shaft diversity decreased from 31.5 ± 6.3% to 21.3 ± 2.2 (P < .001) and vellus hairs decreased from 24.7 ± 6.4 to 19.5 ± 5.4 (P = .02).
Ibrahim IM, Hasan MS, Elsabaa KI, et al. J Cosmet Dermatol, 2021. PMID 33544448
2021 / Randomized controlled trial
In a randomized trial, 78 women aged 18-40 years with PCOS received either 1000 mg resveratrol or 1000 mg placebo daily for 3 months. Compared to placebo, the resveratrol group had a significantly higher regular menstruation rate (76.47% vs. 51.61%; p = 0.03) and lower hair loss (32.10% vs. 68.00%; p = 0.009). No significant differences were found between groups for ovarian and adrenal androgens, SHBG, FAI, glycoinsulinemic metabolism, or lipid profile, and weight did not change relative to placebo.
Mansour A, Samadi M, Sanginabadi M, et al. Clin Nutr, 2021. PMID 33610422
2021 / Randomized controlled trial
Postmenopausal women were randomly assigned to a low-fat, vegan diet including 1/2 cup (86 g) of cooked soybeans daily, or to no diet changes for 12 weeks. Total hot flashes decreased 79% in the intervention group compared to 49% in controls (between-group P = 0.01), and moderate-to-severe hot flashes decreased 84% versus 42% (between-group P = 0.01). Furthermore, 59% (10/17) of the intervention group became free of moderate and severe hot flashes, while the control group saw no change (between-group P < 0.001). Significantly greater improvements were also observed in the intervention group across vasomotor, psychosocial, physical, and sexual quality of life domains.
Barnard ND, Kahleova H, Holtz DN, et al. Menopause, 2021. PMID 34260478
2021 / Pragmatic, multicentre, 2 x 2 factorial randomized controlled trial
A 2 x 2 factorial trial compared progressive exercise (up to 6 sessions) against a single best practice advice session, with or without corticosteroid injection, in 708 adults with rotator cuff disorders. Over 12 months, no evidence of a difference in SPADI score was found between progressive exercise and best practice advice (adjusted mean difference -0.66 [99% CI -4.52 to 3.20]). Similarly, no difference was observed between corticosteroid injection and no injection (adjusted mean difference -1.11 [99% CI -4.47 to 2.26]). No serious adverse events were reported.
Hopewell S, Keene DJ, Marian IR, et al. Lancet, 2021. PMID 34265255
2021 / Controlled trial
Thirteen resistance-trained men were allocated to either cold water immersion (CWI; 10 minutes at 10°C) or a sham intervention immediately following each session of a 2 x 4-week lower body resistance training program (16 total sessions). The training program led to significant increases in muscle fibre pennation angle (p = 0.009), isometric peak force (p = 0.018), and 1/4 squat (p < 0.001), with no differences between groups (all p > 0.05). Perceptual responses also did not differ between groups. CWI demonstrated no functional or perceptual benefits over the sham intervention, and showed no detrimental impact on morphological adaptations.
Wilson LJ, Dimitriou L, Hills FA, et al. J Strength Cond Res, 2021. PMID 34324460
2021 / Randomized placebo-controlled triple-blind clinical trial
In a triple-blind trial, 60 women with endometriosis were randomly assigned to receive usual care plus either 400 mg garlic tablets or identical placebo tablets for three months. Pain was measured before intervention and at one-, two-, and three-month follow-ups using a four-part VAS. The overall severity of pain decreased from 6.51 ± 0.86 to 1.83 ± 1.25 in the garlic group (p < 0.05), but increased from 6.41 ± 1.12 to 6.65 ± 1.37 in the control group (p = 0.02). Repeated measures ANOVA demonstrated a significant difference in pain score changes between the groups (p < 0.001, np2 = 0.572).
Amirsalari S, Behboodi Moghadam Z, Taghizadeh Z, et al. Evid Based Complement Alternat Med, 2021. PMID 34335819
2021 / Randomized triple-blind placebo-controlled clinical trial
Eighty patients with chronic tinnitus followed a 24-hour caffeine-restricted diet and were randomized to receive either a 300-mg caffeine capsule or a placebo (cornstarch). Assessments were performed at baseline and after capsule ingestion using questionnaires (THI, VAS, POMS) and audiometric and otoacoustic evaluations (TEOAE, DPOAE). A significant change in mood (POMS) occurred after caffeine consumption, while THI and VAS scores improved at the second timepoint in both groups. Differences in some audiometry frequencies and otoacoustic measures between baseline and follow-up occurred in both groups but were not clinically relevant, showing that 300 mg of caffeine did not significantly alter tinnitus-related discomfort.
Ledesma ALL, Leite Rodrigues D, Monteiro de Castro Silva I, et al. PLoS One, 2021. PMID 34543285
2021 / Randomized, double-blind, placebo-controlled trial
A 16-week randomized, double-blind, placebo-controlled trial examined the effects of yellow maca (Lepidium meyenii Walpers) in 50 patients with reproductive-related problems. Maca treatment increased sperm concentration by 40% compared to a 76% increase with placebo after 8 and 16 weeks, but the difference was statistically non-significant. No statistically significant changes were observed in hormone levels with maca, aside from a decrease in free testosterone. The authors concluded that the results are insufficient to determine the efficacy of maca on male fertility.
Melnikovova I, Russo D, Fait T, et al. Phytother Res, 2021. PMID 34585449
2021 / Randomized, double-blind, placebo-controlled clinical trial
A randomized, double-blind, placebo-controlled trial evaluated the effect of 500 mg wheat germ capsules taken every 6 hours for 2 days versus placebo in 90 women with moderate to severe postpartum pain. Postpartum pain in women with moderate pain decreased in both groups, with a non-significant greater reduction in the wheat germ group (GEE=0.04). In women with severe pain, the reduction was significantly greater in the wheat germ group compared to placebo (GEE=0.63, p=0.007). In addition, mefenamic acid use was significantly lower in the wheat germ group (p=0.04), and no side effects were reported.
Mehravar S, Amir Ali Akbari S, Nasiri M, et al. Avicenna J Phytomed, 2021. PMID 34804895
2021 / Open-labeled noncontrolled clinical trial
An open-labeled noncontrolled clinical trial evaluated the effect of 500 mg/day oral resveratrol monotherapy for 90 days in knee osteoarthritis patients. Resveratrol administration led to a nonsignificant decrease in serum Coll 2-1 and a significant increase in serum aggrecan. Pain scores measured by VAS and KOOS significantly improved after 30 days, alongside significant improvements in all KOOS subscale areas that persisted through three months.
Marouf BH Biomed Res Int, 2021. PMID 34805399
2020 / Topical application study and pilot nutrition intervention study
A study evaluated the effects of pea sprout extract applied topically and consumed orally. In 10 volunteers, topical application of a fluid containing 2% pea sprout extract increased expression of FGF7 and noggin by 56% and 85%, respectively. In a subsequent pilot study of 21 volunteers, daily intake of 100 mg pea sprout extract (AnaGain™ Nu) for 8 weeks significantly reduced hair loss starting after 28 days of treatment (p < 0.002). No adverse events were reported.
Grothe T, Wandrey F, Schuerch C Phytother Res, 2020. PMID 31680356
2020 / Randomized controlled trial
A randomized controlled trial examined the effects of 10 g/day of collagen peptides (CP) versus placebo for 12 weeks in 167 physically active individuals with self-reported knee pain. Both groups experienced similar reductions in VAS pain scores (-1.6 ± 2.4 with CP vs. -1.9 ± 2.6 with placebo, p = 0.42). KOOS and Lysholm function scores increased significantly in both groups (p < 0.001), but the increases did not differ between groups (p = 0.28 and p = 0.76, respectively). CP also showed no effect on inflammatory, cartilage, or bone biomarkers (p > 0.05).
Bongers CCWG, Ten Haaf DSM, Catoire M, et al. Appl Physiol Nutr Metab, 2020. PMID 31990581
2020 / Randomized crossover trial
In a randomized crossover trial, 15 participants underwent 4 days of an alkalizing (BASE) or acidizing (ACID) diet under normoxic and normobaric hypoxic conditions. Anaerobic exercise performance was evaluated using the portable tethered sprint running (PTSR) test. Urinary pH, blood pH, blood bicarbonate concentration, and base excess were significantly higher following the BASE diet compared with the ACID diet (p < 0.001). However, there were no differences between BASE and ACID conditions for any of the PTSR-related parameters, indicating that diet-induced metabolic changes did not improve anaerobic performance.
Limmer M, Sonntag J, de Marées M, et al. Nutrients, 2020. PMID 32143278
2020 / Randomized, double-blind, placebo-controlled trial
Sixty-five healthy women aged 20-39 years were randomized to receive daily apple polyphenol tablets (300 or 600 mg/day) or a placebo for 12 weeks. Continuous supplementation with apple polyphenols significantly prevented UV irradiation-induced skin pigmentation, including improvements in erythema, melanin, and L values, though a dose-dependent relationship was not clearly observed. No significant differences were detected between the groups regarding skin water content and trans-epidermal water loss.
Shoji T, Masumoto S, Moriichi N, et al. Nutrients, 2020. PMID 32294883
2020 / Randomized clinical trial
A randomized trial assessed the antimicrobial efficacy of mouthwashes containing EGCG, green tea, chlorhexidine (CHX), or distilled water rinsed for one minute in 47 children. All rinses significantly reduced counts of mutans streptococci and lactobacilli before versus after rinsing. For mutans streptococci, the percentage reductions were 95.5% for CHX, 79.9% for EGCG, 68.3% for green tea, and 50.6% for distilled water. For lactobacilli, reductions were 86.02% for CHX, 72.09% for EGCG, 59.17% for green tea, and 41.96% for distilled water.
Vilela MM, Salvador SL, Teixeira IGL, et al. Arch Oral Biol, 2020. PMID 32361019
2020 / Intervention trial with matched controls
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
Pirinen E, Auranen M, Khan NA, et al. Cell Metab, 2020. PMID 32386566
2020 / Randomized double-blind placebo-controlled trial
Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.
Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445
2020 / Crossover, double-masked, randomized clinical trial
In a double-masked crossover trial, 57 glaucoma patients received oral placebo or nicotinamide (1.5 g/day for 6 weeks, then 3.0 g/day for 6 weeks) followed by crossover without washout. Saturated PhNR amplitude (Vmax) improved by 14.8% (95% CI: 2.8%, 26.9%; P = .02) on nicotinamide versus 5.2% (95% CI: -4.2%, 14.6%; P = .27) on placebo. The Vmax ratio improved by 12.6% (95% CI: 5.0%, 20.2%; P = .002) following nicotinamide compared to 3.6% (95% CI: -3.4%, 10.5%; P = .30) on placebo. Additionally, 27% of participants improved visual field mean deviation by ≥1 dB on nicotinamide with fewer deteriorating (4%) compared to placebo (P = .02).
Hui F, Tang J, Williams PA, et al. Clin Exp Ophthalmol, 2020. PMID 32721104
2020 / Randomized, double-blind, placebo-controlled crossover trial
In a 24-month randomized, double-blind, placebo-controlled crossover trial, 125 healthy postmenopausal women received resveratrol (75 mg twice daily) or placebo to assess effects on well-being and cerebrovascular function. Resveratrol supplementation significantly reduced composite pain score (P < 0.001), especially in overweight participants, and this reduction was associated with improved cerebrovascular responsiveness to hypercapnia (R = -0.329, P = 0.014). Somatic menopausal symptoms (P = 0.024) and general well-being (P = 0.010) were also improved.
Thaung Zaw JJ, Howe PRC, Wong RHX Menopause, 2020. PMID 32881835
2020 / Multicenter, randomized, double-blind, placebo-controlled trial
One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).
Lee JY, Lee C, Yoon SH, et al. Taiwan J Obstet Gynecol, 2020. PMID 32917317
2020 / Randomized two-group parallel-arm study
A randomized parallel-arm study evaluated the effects of 16 weeks of either 85 g or 250 g of Ataulfo mango intake on facial wrinkles and erythema in healthy postmenopausal women with Fitzpatrick skin type II or III. In the 85 g group, deep wrinkle severity decreased significantly after 8 weeks (p = 0.007) and 16 weeks (p = 0.03) compared to baseline, while cheek erythema increased (p = 0.04). In contrast, the 250 g group showed significant increases after 16 weeks in average wrinkle severity (p = 0.049), average wrinkle length (p = 0.007), fine wrinkle severity (p = 0.02), and emerging wrinkle severity (p = 0.02).
Fam VW, Holt RR, Keen CL, et al. Nutrients, 2020. PMID 33158079
2019 / Parallel randomized clinical trial
A parallel randomized clinical trial evaluated the effect of consuming 240 ml of soy milk daily as part of a 500-calorie deficit diet compared to the deficit diet alone for 8 weeks in 70 patients with NAFLD. The soy milk group showed significantly greater reductions in serum alanine aminotransferase (-12.06 ± 17.61 IU/L vs. -5 ± 8.58 IU/L, p = 0.04) and hs-CRP (-1.32 ± 1.60 mg/L vs. -0.36 ± 1.54 mg/L, p = 0.01). However, changes in fatty liver grade, other liver enzymes (AST, ALP, GGT), lipid profiles, and anthropometric indices did not differ significantly between groups.
Eslami O, Shidfar F, Maleki Z, et al. J Am Coll Nutr, 2019. PMID 30028245
2019 / Matched controlled trial
Twenty-four resistance-trained males completed a lower-body resistance training session and were matched into cold water immersion (10 min at 10 °C), whole-body cryotherapy (3- and 4 min at -85 °C), or placebo groups. While whole-body cryotherapy attenuated soreness at 24 hours and positively influenced peak force at 48 hours compared to cold water immersion and placebo, many remaining outcomes were trivial, unclear, or favored placebo. Except for CRP at 24 hours, neither cryotherapy intervention reduced inflammatory responses compared to placebo.
Wilson LJ, Dimitriou L, Hills FA, et al. Eur J Appl Physiol, 2019. PMID 30310979
2019 / Randomised, double-blinded, placebo-controlled crossover trial
A randomized, double-blinded, placebo-controlled crossover trial evaluated the effects of 20 mg/day oral saffron versus placebo for 3 months each in 100 adults with mild/moderate age-related macular degeneration. Mean BCVA improved by 0.69 letters (p = 0.001) and mean-pooled mfERG latency decreased by 0.17 ms (p = 0.04) on saffron compared to placebo. In participants also taking AREDS supplements, mean BCVA improved by 0.73 letters (p = 0.006) and mfERG response density improved by 2.8% (p = 0.038). Adverse events did not differ significantly between groups (p > 0.10).
Broadhead GK, Grigg JR, McCluskey P, et al. Graefes Arch Clin Exp Ophthalmol, 2019. PMID 30343354